S L Ferrari
Overview
Explore the profile of S L Ferrari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bonnet N, Pierroz D, Ferrari S
J Musculoskelet Neuronal Interact
. 2008 Jul;
8(2):94-104.
PMID: 18622078
Evidence that leptin regulates bone turnover in part through a central nervous system (CNS)/beta-adrenergic system relay has driven attention towards the potential therapeutic benefits of beta-adrenergic blockade to improve bone...
12.
Karasik D, Ferrari S
Ann Hum Genet
. 2008 May;
72(Pt 5):696-714.
PMID: 18485052
Common diseases result from the complex relationship between genetic and environmental factors. The aim of this review is to provide perspective for a conceptual framework aimed at studying the interplay...
13.
Hamrick M, Ferrari S
Osteoporos Int
. 2007 Oct;
19(7):905-12.
PMID: 17924050
Loss of body weight is associated with bone loss, and body weight gain is associated with increased bone formation. The molecular mechanisms linking body weight, body composition, and bone density...
14.
Rey A, Manen D, Rizzoli R, Ferrari S, Caverzasio J
Bone
. 2007 Apr;
41(1):59-67.
PMID: 17434817
Increased bone formation by PTH mainly results from activation of osteoblasts, an effect largely mediated by the cAMP-PKA pathway. Other pathways, however, are likely to be involved in this process....
15.
Ferrari S, Deutsch S, Baudoin C, Cohen-Solal M, Ostertag A, Antonarakis S, et al.
Bone
. 2005 Sep;
37(6):770-5.
PMID: 16168727
Mutations in the low-density lipoprotein receptor-related protein 5 gene (LRP5) have demonstrated the role of LRP5 in bone mass acquisition. LRP5 variants were recently reported to contribute to the population-based...
16.
Ferrari S, Pierroz D, Glatt V, Goddard D, Bianchi E, Lin F, et al.
Endocrinology
. 2005 Feb;
146(4):1854-62.
PMID: 15705780
Intermittent PTH administration increases bone turnover, resulting in net anabolic effects on bone. These effects are primarily mediated by intracellular cAMP signaling. However, the molecular mechanisms that regulate PTH activity...
17.
Ferrari S, Garnero P, Humphries S, Greenspan S
J Clin Endocrinol Metab
. 2003 Jan;
88(1):255-9.
PMID: 12519862
IL-6 is a pleiotropic cytokine that plays a critical role in bone resorption. We describe two allelic variants in the IL-6 promoter, -572 and -174 G-->C, that alone and in...
18.
19.
Rizzoli R, Bonjour J, Ferrari S
J Mol Endocrinol
. 2001 Mar;
26(2):79-94.
PMID: 11241160
Osteoporosis is a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue. At a given age, bone mass results from the amount of bone acquired...
20.
Ferrari S, Garnero P, Emond S, Montgomery H, Humphries S, Greenspan S
Arthritis Rheum
. 2001 Feb;
44(1):196-201.
PMID: 11212160
Objective: To examine functional interleukin-6 (IL-6) -174 G-->C allelic variants in relation to bone turnover and bone mineral density (BMD) in postmenopausal women. Methods: Four hundred thirty-four healthy women living...